financetom
Business
financetom
/
Business
/
Fenbo Receives Nasdaq Noncompliance Notice
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fenbo Receives Nasdaq Noncompliance Notice
Jan 28, 2025 8:19 AM

10:57 AM EST, 01/28/2025 (MT Newswires) -- Fenbo Holdings ( FEBO ) said Tuesday it received a Nasdaq noncompliance notice on Jan. 16 for failing to hold its annual meeting of stockholders within 12 months for its fiscal year ended on Dec. 31, 2023.

The company has 45 calendar days, or until March 3, to submit a plan for regaining compliance, it added.

The regulator's notification has no immediate impact on the company's Nasdaq listing, Fenbo ( FEBO ) said.

Price: 1.51, Change: +0.02, Percent Change: +1.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Mar 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Computershare Trustees (Jersey) Limited as Trustee of Senior Plc Employee Benefit Trust (b) Owner or controller of interests and short positions disclosed,...
Infinity Natural Resources Plans $500 Million Private Debt Offering
Infinity Natural Resources Plans $500 Million Private Debt Offering
Mar 17, 2026
09:53 AM EDT, 03/17/2026 (MT Newswires) -- Infinity Natural Resources ( INR ) said Tuesday its unit intends to offer $500 million of senior notes due 2031 in a private placement, subject to market conditions. The unit plans to use the net proceeds to repay outstanding borrowings under its credit agreement alongside funding general corporate purposes, Infinity Natural Resources (...
Polaryx Therapeutics Says FDA Grants Fast Track Status to PLX-200
Polaryx Therapeutics Says FDA Grants Fast Track Status to PLX-200
Mar 17, 2026
09:48 AM EDT, 03/17/2026 (MT Newswires) -- Polaryx Therapeutics ( PLYX ) said Tuesday the US Food and Drug Administration has granted Fast Track designation to PLX-200, a potential treatment for late-infantile neuronal ceroid lipofuscinosis (CLN2) disease The designation allows for more frequent interaction with the agency and the possibility of a rolling review for a future marketing application, the...
Stratasys Says TrueDent Product Gets Further Certification in Europe
Stratasys Says TrueDent Product Gets Further Certification in Europe
Mar 17, 2026
09:54 AM EDT, 03/17/2026 (MT Newswires) -- Stratasys ( SSYS ) said Tuesday its TrueDent resins have obtained CE marking as a Class IIa medical device. The expanded indication now includes intraoral removables for use of over 30 days, and crowns and bridges, which will allow dental laboratories to address a wider range of cases, the company said. TrueDent-D was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved